Ajooni Biotech DuPont analysis

·UnclassifiedChart ›

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.74×	0.75×	0.78×	0.72×	0.71×
	1.21×	1.42×	1.67×	2.20×	0.90×
	2.1%	2.2%	2.3%	1.7%	2.4%
	1.69×	1.69×	1.61×	1.69×	1.27×
	1.32×	1.32×	1.08×	1.11×	—
	4.1%	5.3%	5.1%	5.1%	—
	4.8%	4.8%	5.2%	5.1%	2.7%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

AJOONI₹2.93

Ajooni Biotech Limited

· Unclassified

₹ CrorePeersTOUCHWOOD RKEC RAJMET BANKA AAKASH GANGAFORGE GLOBE AGROPHOSMcap ₹50.5 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.71	0.72	0.78	0.75	0.74
Interest Burden (Pretax/EBIT) ×	0.90	2.20	1.67	1.42	1.21
EBIT Margin %	2.36	1.70	2.26	2.22	2.07
Asset Turnover ×	1.27	1.69	1.61	1.69	1.69
Financial Leverage (Assets/Equity) ×	—	1.11	1.08	1.32	1.32
ROE (5-step product, year-end total equity) %	—	5.07	5.11	5.29	4.12
ROE (owners' profit / average owners' equity) %	2.70	5.06	5.16	4.82	4.82

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.